Uike P, Hiwarkar P, Malkar V, Aswalle K. Profile of multi drug resistant (MDR) and rifampicin resistant TB patients treated under category IV of RNTCP. Int J Basic Clin Pharmacol [Internet]. 2017 Mar. 25 [cited 2025 Oct. 24];6(4):784-7. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/1446